Valneva (NASDAQ:VALN) Shares Gap Up – Here’s What Happened

Valneva SE (NASDAQ:VALN)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $7.00, but opened at $7.48. Valneva shares last traded at $7.54, with a volume of 18,726 shares trading hands.

Analysts Set New Price Targets

Separately, HC Wainwright restated a “buy” rating and set a $18.00 price objective on shares of Valneva in a research report on Friday, January 31st.

Valneva Price Performance

The stock’s 50-day moving average price is $4.63 and its 200 day moving average price is $5.63. The company has a quick ratio of 2.25, a current ratio of 2.78 and a debt-to-equity ratio of 0.70. The firm has a market capitalization of $615.14 million, a price-to-earnings ratio of -58.32 and a beta of 1.98.

Hedge Funds Weigh In On Valneva

An institutional investor recently bought a new position in Valneva stock. ABC Arbitrage SA bought a new position in Valneva SE (NASDAQ:VALN) in the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 19,244 shares of the company’s stock, valued at approximately $84,000. 11.39% of the stock is owned by hedge funds and other institutional investors.

About Valneva

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; IXCHIQ, a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus; and VLA2001, an inactivated whole-virus COVID-19 vaccine.